MedPath

Use of Resorbable Prosthetic Mesh "Ante Rectus" as Prevention of Parastomal Hernia.

Not Applicable
Recruiting
Conditions
Parastomal Hernia
Registration Number
NCT04749329
Lead Sponsor
Azienda Sanitaria Locale Napoli 2 Nord
Brief Summary

The aim of this study was to assess feasibility, potential benefits and safety of a prophylactic biosynthetic mesh placed at the time of colostomy.

Detailed Description

Several surgical scenarios include colon diversion as part of their management. Among them, the most frequent conditions requiring colostomy are abdominal malignancies, large bowel diverticulitis, Inflammatory Bowel Disease, bowel obstruction or perforation and postoperative complications such as anastomotic leakage. Colostomy related morbidity includes retraction, infection, prolapse, skin problems and parastomal hernia. Parastomal Hernia is a quite common late complication, with a clinical rate up to 55%, reaching 80% when assessed by Computer Tomography. Although Parastomal Hernia is often asymptomatic, significant morbidity exists, including pain, intermittent obstruction, stoma leakage, skin irritation and pouching, often reducing patients' Quality of Life. Several surgical options are available for Parastomal Hernia repair, many of them supporting the use of mesh to strengthen the fascia. However, results are often disappointing with quite high recurrence rates, rising up to 33%, even with the use of a mesh. Several studies have been published, testing effectiveness and safety of a prophylactic mesh in vertical laparotomy closure to prevent incisional hernia.

The aim of this study was to assess feasibility, potential benefits and safety of a prophylactic biosynthetic mesh placed at the time of colostomy.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
110
Inclusion Criteria
  • age > 18 years
  • endo colostomy
  • Informed consent
Exclusion Criteria
  • age < 18 years;
  • life expectancy < 24 months (as estimated by the operating surgeon)
  • pregnancy
  • immunosuppressant therapy within 2 weeks before surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rate of Parastomal Hernia at clinical control.24 months

Detect of paratoia hernia

Secondary Outcome Measures
NameTimeMethod
Number of patients affected by Superficial surgical site infectionsWithin 30 days postoperatively

Superficial infections according to Clavien-Dindo criteria

Number of patients affected by Deep surgical site infectionsWithin 30 days postoperatively

Deep surgical site infections according to Clavien-Dindo criteria

Rate of Parastomal Hernia at tomography observation.24 months follow-up

detect of parastomal hernia

Trial Locations

Locations (2)

Aslnapoli2Nord

🇮🇹

Naples, Italy

francesco Pizza

🇮🇹

Naples, Italy

Aslnapoli2Nord
🇮🇹Naples, Italy
francesco pizza, md phd
Contact
francesco.pizza@libero.it
dario d'antonio, md
Contact
dario.dantonio@libero.it

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.